目錄:MedChemExpress LLC>>生化試劑>> Ascrinvacumab | MCE
CAS | 1463459-96-2 | 供貨周期 | 現貨 |
---|---|---|---|
規(guī)格 | 5 mg | 貨號 | HY-P99353 |
應用領域 | 醫(yī)療衛(wèi)生,化工,生物產業(yè),制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
CAS No. : 1463459-96-2
產品活性:Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).
研究領域:Protein Tyrosine Kinase/RTK
作用靶點:Anaplastic lymphoma kinase (ALK)
In Vitro: Ascrinvacumab binds to cellular human ALK1 with a Kd value of 7 nm.Ascrinvacumab (30 min) blocks bone morphogenetic protein 9 (BMP9)- and fetal calf serum (FCS)-induced responses and mitigates BMP9-induced intensity and duration of Smad1 phosphorylation.Ascrinvacumab (0.01-10 μg/mL; 2 h) inhibits BMP9 binding to ALK1.Ascrinvacumab (40 μg/mL; 2 h) potently inhibits endothelial sprouting in human umbilical vein endothelial cells (HUVECs).
In Vivo: Ascrinvacumab decreases human vessel density and improves antitumor efficacy when combined with bevacizumab (anti-VEGF) in mouse chimera tumor model.
相關產品:ALK/ROS1-IN-1 | Ceritinib | KRCA-0008 | Iruplinalkib | ALK-IN-22 | JH-VIII-157-02 | NVP-TAE 684 | TL13-110 | Brigatinib-13C6 | Alectinib | Zotizalkib | M4K2234 | Con B-1 | Ficonalkib | Entrectinib | 2-Keto Crizotinib | ALK inhibitor 1 | ALK-IN-6 | GSK1838705A | EML4-ALK kinase inhibitor 1 | F-1 | ALK-IN-1 | MS4077 | ALK kinase inhibitor-1 | CJ-2360 | Envonalkib | MS4078 | ALK-IN-5 | X-376
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產品,廣泛應用于新藥研發(fā)、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業(yè)技術服務;
• 設有專業(yè)的實驗中心和嚴格的質控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告,確保產品的高純度、高品質;
• 產品的生物活性多經各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。